GlassScriptPhysician profile
Natalie Rizk
NPI 1841517182
$1,791.56
in general payments reported to CMS, 2019-2025
13 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.99 · 2023: $481 · 2024: $1,154 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,261 · Travel and Lodging: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.62 |
| Travel and Lodging | $506.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $836.67 | 2024 | |
| Dilon Technologies, INC. | $310.01 | 2023-2024 | Hemoblast Bellows |
| Tela Bio, INC. | $182.51 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sirius Medical Systems | $137.36 | 2023 | Pintuition |
| Depuy Synthes Sales INC. | $94.15 | 2024 | Matrixrib |
| Merck Sharp & Dohme LLC | $46.18 | 2025 | Keytruda, Lynparza |
| Stryker Corporation | $44.52 | 2023 | Spy-Phi System |
| Integra Lifesciences Corporation | $32.50 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $28.82 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Incyte Corporation | $24.87 | 2025 | Monjuvi, Zynyz |
| Convatec INC. | $23.99 | 2022 | |
| Tactile Systems Technology INC | $16.00 | 2024 | Entre Plus, Flexitouch Plus |
| Sanara Medtech INC. | $13.98 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Rizk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.